David Jonathan Cohen, MD
On the web

Overview
I am involved in numerous clinical protocols investigating new immunosuppressive drugs and/or new combinations of existing medications in renal transplant patients, both newly transplanted patients and those with long-term functioning transplants.
Areas of Expertise / Conditions Treated
- Hypertension
- Kidney Transplant
- Pancreas Transplant
- Transplantation Nephrology
Academic Appointments
- Professor of Medicine at CUMC
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Languages
- French
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
Cigna
Emblem/GHI
Emblem/HIP
Empire Blue Cross/Blue Shield
Empire Blue Cross Blue Shield HealthPlus
Local 1199
MagnaCare (National)
Medicare
Multiplan
UnitedHealthcare
WellCare
World Trade Center Health Plan
Credentials & Experience
Education & Training
- Albert Einstein College of Medicine - Yeshiva University
- Internship: Mount Sinai Hospital
- Residency: Mount Sinai Hospital
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowship: Brigham & Women's Hospital
Board Certifications
- Internal Medicine
- Nephrology
Research
I am interested in immunosuppressive drug protocols in renal transplantation, as well as renal disease occurring in recipients of non-renal transplants.
Selected Publications
- Wilkinson AH, Cohen DJ. (1999) Renal failure in recipients of non-renal solid organ transplants. J Amer Soc Nephrol 10:1136-45
- The Mycophenolate Mofetil Acute Rejection Study Group. (2001) Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. Transplantation 71:1091-7
- Lin J, Valeri AM, Cohen DJ, Radhakrishnan J. (2002) Angiotensin converting enzyme (ACE) inhibition in chronic allograft nephropathy. Transplantation 73:783-8
- Adams PL, Cohen DJ, Danovitch GM, et al. (2002) The nondirected live-kidney donor: ethical considerations and practice guidelines. Transplantation 74:582-90
For a complete list of publications, please visit PubMed.gov(link is external and opens in a new window)